SCHEMBL10744989

SCHEMBL10744989

S=c1c2ccccc2[se]n1-c1nc2ccccc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2A Q92830 1/20 0.47
▸ KAT2B Q92831 1/20 0.47
▸ TP53 P04637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ NPC1 O15118 7/20 0.43
▸ RAB9A P51151 7/20 0.43
▸ NPSR1 Q6W5P4 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ POLB P06746 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ SLC11A2 P49281 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10746112 0.82 NPC1 (0.43) TP53NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL5916972 0.82 KAT2A (0.57) KAT2AKAT2BTP53HSD17B10NPSR1
SCHEMBL10744992 0.81 MAPT (0.52) TP53NPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL10746279 0.80 MAPT (0.48) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL10745118 0.79 RAB9A (0.53) NPC1RAB9ANPSR1SMN1; SMN2MEN1
SCHEMBL10748167 0.77 ALDH1A1 (0.51) TP53HSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL10746643 0.75 METAP2 (0.38) TP53HSD17B10NPC1RAB9ANPSR1
SCHEMBL10745614 0.75 METAP2 (0.35) TP53HSD17B10NPSR1MEN1KMT2A
SCHEMBL10501392 0.73 METAP2 (0.34) TP53HSD17B10NPSR1MEN1KMT2A
SCHEMBL10502231 0.73 METAP2 (0.37) TP53HSD17B10NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback